Varied response of spontaneous tumors to antiangiogenic agents

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Conventional cancer therapies rely on drug and oxygen delivery, which can be compromised by antiangiogenic agents.
• Understanding how antiangiogenic agents affect tumor vascular function and oxygenation is crucial for optimizing combination therapies.
• Assessing the translational relevance of experimental tumor models is essential for predicting clinical outcomes.

Purpose of the Study:

• To investigate the impact of three antiangiogenic agents (endostatin, anti-VEGFR-2 [DC101], and celecoxib) on tumor pathophysiology.
• To compare the effects of these agents on tumor vascular function, including total and perfused vessels and hypoxia.
• To evaluate whether experimental results from transplanted tumors accurately reflect responses in spontaneous tumors.

Main Methods:

• Tumor-bearing mice were treated with endostatin, anti-VEGFR-2 (DC101), or celecoxib.
• Tumor vascularization was assessed using anti-CD31 staining for total vessels.
• Tumor perfusion was evaluated using DiOC7, and hypoxia was measured by EF5 uptake.

Main Results:

• DC101 significantly inhibited tumor growth and increased vessel spacing and hypoxia.
• Endostatin increased total vessel spacing and hypoxia but had less impact than DC101.
• Celecoxib demonstrated no significant effects on tumor pathophysiology. Transplanted tumor models generally mirrored responses in spontaneous tumors.
• DC101 efficacy varied, with approximately half of spontaneous tumors showing inhibited growth while others were unaffected.

Conclusions:

• Antiangiogenic agents, particularly DC101, can detrimentally alter tumor vascular function and increase hypoxia, potentially impacting combination therapy efficacy.
• Experimental findings in transplanted tumors generally correlate with spontaneous tumor responses, supporting their use as models.
• Significant variability in antiangiogenic response among tumors necessitates further investigation into the underlying mechanisms driving differential sensitivity.